These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11746626)

  • 21. Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease.
    Bruno V; Freitas ME; Mancini D; Lui JP; Miyasaki J; Fox SH
    Can J Neurol Sci; 2018 Jan; 45(1):23-29. PubMed ID: 29334040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
    Dressler D; Kupsch A; Seitzinger A; Paus S
    Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia.
    Han Y; Stevens AL; Dashtipour K; Hauser RA; Mari Z
    J Neurol; 2016 Apr; 263(4):772-80. PubMed ID: 26914922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.
    Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W;
    J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injections.
    Häkkinen A; Ylinen J; Rinta-Keturi M; Talvitie U; Kautiainen H; Rissanen A
    Arch Phys Med Rehabil; 2004 Oct; 85(10):1684-8. PubMed ID: 15468031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
    Dowson AJ; Kilminster SG; Salt R
    Drugs R D; 2008; 9(3):147-58. PubMed ID: 18457467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cause or effect: Altered brain and network activity in cervical dystonia is partially normalized by botulinum toxin treatment.
    Brodoehl S; Wagner F; Prell T; Klingner C; Witte OW; Günther A
    Neuroimage Clin; 2019; 22():101792. PubMed ID: 30928809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictable variables for short- and long-term botulinum toxin treatment response in patients with cervical dystonia.
    Felicio AC; Godeiro-Junior C; de Carvalho Aguiar P; Borges V; Silva SM; Ferraz HB
    Neurol Sci; 2009 Aug; 30(4):291-4. PubMed ID: 19468681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-utility analysis of botulinum toxin type A products for the treatment of cervical dystonia.
    Kazerooni R; Broadhead C
    Am J Health Syst Pharm; 2015 Feb; 72(4):301-7. PubMed ID: 25631837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 32. Postural control and the relation with cervical sensorimotor control in patients with idiopathic adult-onset cervical dystonia.
    De Pauw J; Mercelis R; Hallemans A; Van Gils G; Truijen S; Cras P; De Hertogh W
    Exp Brain Res; 2018 Mar; 236(3):803-811. PubMed ID: 29340715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatosensory temporal discrimination tested in patients receiving botulinum toxin injection for cervical dystonia.
    Scontrini A; Conte A; Fabbrini G; Colosimo C; Di Stasio F; Ferrazzano G; Berardelli A
    Mov Disord; 2011 Mar; 26(4):742-6. PubMed ID: 21506155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.
    Misra VP; Colosimo C; Charles D; Chung TM; Maisonobe P; Om S;
    J Neurol; 2018 Feb; 265(2):402-409. PubMed ID: 29270685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin A during pregnancy: a survey of treating physicians.
    Morgan JC; Iyer SS; Moser ET; Singer C; Sethi KD
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):117-9. PubMed ID: 16361610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry.
    Trosch RM; Espay AJ; Truong D; Gil R; Singer C; LeWitt PA; Lew MF; Tagliati M; Adler CH; Chen JJ; Marchese D; Comella CL
    J Neurol Sci; 2017 May; 376():84-90. PubMed ID: 28431634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensorimotor network in cervical dystonia and the effect of botulinum toxin treatment: a functional MRI study.
    Opavský R; Hluštík P; Otruba P; Kaňovský P
    J Neurol Sci; 2011 Jul; 306(1-2):71-5. PubMed ID: 21492880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left-right comparison.
    Wollina U; Karamfilov T
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):40-2. PubMed ID: 11952288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.
    Yi YG; Kim K; Yi Y; Choi YA; Leigh JH; Bang MS
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral Lower Sternocleidomastoid Botulinum Toxin Injections to Address Refractory Anterocollis.
    Peng-Chen Z; Thompson A; Rodriguez RL
    Neurologist; 2016 Mar; 21(2):30-1. PubMed ID: 26926853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.